← Back to headlines
AI-Developed Drug Reverses Biological Age in Clinical Trial
An experimental drug developed from scratch by AI algorithms, Rentosertib, reduced the biological age of patients with a rare lung disease by 3-4 years in a study published in Nature Biotechnology.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.

